Merck KGaA begins phase 3 trial for colorectal cancer drug

May 21, 2026 8:01 AM

Merck KGaA, Darmstadt, Germany, announced that the first patient has been dosed in a Phase 3 clinical trial for precemtabart ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found